Abstract:Objective:To explore the regulation of group 2 innate lymphoid cells (ILC2) recruitment by interleukin-33 (IL-33) , to examine the effect of ILC2 on macrophages during peritoneal infection in sepsis and to further elucidate the immune regulatory mechanism of peritoneal infection.Methods:Forty healthy 6 to 8 week-old male C57BL/6 wild-type mice, twenty Il-33 -/- mice on a C57BL/6 background, and ten IL-33 receptor ST2 knockout (Il1rl1 -/-) mice were bred and housed in the SPF Medical Animal Center of Zhejiang University and the University of Pittsburgh, USA. Receipts of sham surgery were designated as controls and underwent identical surgical procedures were septic mice. IL-33 protein was administered to rmIL-33 group via an exogenous intraperitoneal injection and the changes of ILC2 and its intracellular cytokine levels in peritoneal lavage fluid were detected by flow cytometry. The effects of IL-9 and IL-13 secreted by ILC2 on phagocytic ability of macrophages were confirmed by in vitro experiments. Statistical analysis was performed with t-test or one-way ANOVA test. Results:Compared with ILC2 before/after IL-33 stimulation, the proportion of ILC2 in Lin-CD45 + cells of abdominal cavity increased [(9.90±0.80) vs. (18.43±0.46) ]and the proportion of ILC2 in abdominal cavity jumped after IL-33 stimulation and the difference was statistically significant ( P<0.001). The number of ILC2 in abdominal cavity was [(5 786.00±289.50) vs. (17 820.00±324.30) ]and the number of ILC2 spiked in abdominal cavity after IL-33 stimulation and the difference was statistically significant ( P<0.001). C57BL/6 wild-type mice had a marked increase of peritoneal ILC2 recruitment as compared with control group at 24 h postoperatively [(20.50±0.59) vs. (10.83±1.01) ]and the difference was statistically significant ( P=0.001). However, ILC2 in peritoneal cavity of Il-33 -/- and Il1rl1 -/- mice showed no change at 24 h postoperatively. Moreover, the proportion of ILC2 in Il-33 -/- mice were significantly increased after IL-33 stimulation compared to non-stimulation group (10.53±0.47 vs. 19.43±0.87, P<0.001) , so as in the CLP induced septic mice (10.13±0.57 vs. 21.37±0.86, P<0.001). The study of cytokine levels secreted by ILC2 recruited from abdominal cavity showed that the levels of IL-9 and IL-13 secreted by ILC2 in abdominal cavity increased markedly at 12 h postoperatively and the contents of IL-9 before/after operation were [(16.53±0.74) vs. (24.67±1.45) ]and the differences were statistically significant ( P= 0.007). The proportions of IL-13 at pre/post-operation were [(15.40±0.87) vs. (29.40±0.95) ]and the differences were statistically significant ( P<0.001) while the contents of IL-4 were [(6.14±0.59) vs. (5.89±1.05) ]and the differences were not statistically significant ( P=0.836). An intraperitoneal injection of recombinant IL-33 protein promoted the recruitment of CD45 +F4/80 + macrophages in peritoneal cavity and the proportions before/after injection were [(52.40±1.70) vs. (72.40±2.02) ]and the difference was statistically significant ( P=0.002). Under the action of IL-9/13 secreted by ILC2, phagocytic ability of macrophages was markedly elevated as compared with control group. Phagocytic ability of macrophages under the action of IL-9 was [(61.27±1.46) vs. (48.30±1.65) ]and phagocytic ability of macrophages under the action of IL-13 was [(61.63±2.03) vs. (48.30±1.65) ]and the difference was statistically significant ( P=0.007). Conclusions:IL-33 promotes ILC2 and macrophage recruitment during peritoneal sepsis. And the recruitment of peritoneal ILC2 depends on IL-33/ST2 signaling pathway. Peritoneal ILC2 derived cytokines IL-9 and IL-13 enhance the phagocytosis of macrophages.

Activation of TLR9 signaling suppresses the immunomodulating functions of CD55lo fibroblastic reticular cells during bacterial peritonitis

TLR9 Modulates Peritoneal Immunity Via Regulating the Biology of CD9hi Fibroblastic Reticular Cells

TLR9 Signaling in Fibroblastic Reticular Cells Regulates Peritoneal Immunity.

Roles of Toll-like Receptors in Regulating Fibroblastic Reticular Cells Pathobiology During Sepsis

SINGLE NUCLEOTIDE POLYMORPHISM IN IFN WAS ASSOCIATED WITH ACUTE REJECTION AFTER LIVER TRANSPLANTATION

CD39+ Regulatory T Cells Suppress Generation and Differentiation of Th17 Cells in Human Malignant Pleural Effusion Via a LAP-dependent Mechanism

Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases

Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells Via the ERK/β-catenin Pathway.

IL-33 regulated group 2 innate lymphoid cells promoted the phagocytosis of peritoneal macrophages during sepsis

T lymphocytes maintain structure and function of fibroblastic reticular cells via lymphotoxin (LT)-B

Fibroblastic reticular cells orchestrate long-term graft survival following recipient treatment with CD40 ligand-targeted costimulatory blockade

P005 Exosome miR-132-3p derived from Adipose Stem Cells in Creeping fat Regulates RASA1/ERK1/2-dependant Lymphatic Functions and Improve Colitis and Mesenteritis

Infliximab Modifies CD74-mediated Lymphatic Abnormalities and Adipose Tissue Alterations in Creeping Fat of Crohn's Disease.

Lymph Node Fibroblastic Reticular Cells Attenuate Immune Responses Through Induction of Tolerogenic Macrophages at Early Stage of Transplantation

TLR9 Limits Enteric Antimicrobial Responses and Promotes Microbiota Based Colonization Resistance during Citrobacter rodentium Infection.

Abstract LB028: Reprogramming of tumor-infiltrating immune cells using a tumor-associated macrophage-targeted TLR7 agonist

Fas signaling-mediated T H 9 cell differentiation favors bowel inflammation and antitumor functions

Fatty Acid Oxidation Promotes Apoptotic Resistance and Proinflammatory Phenotype of CD4+ Tissue-resident Memory T cells in Crohn's Disease

Metabolic Reprogramming of Fibroblastic Reticular Cells in Immunity and Tolerance

The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model

Macrophage-Regulatory T Cell Interactions Promote Type 2 Immune Homeostasis Through Resistin-Like Molecule α